Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Minority health and health disparities: definitions and parameters [updated March 31, 2021].(Available at:) (Accessed June 14, 2022)
- Estimating the economic burden of racial health inequalities in the United States.Int J Health Serv. 2011; 41: 231-238
- Achieving health equity: a guide for health care organizations.IHI White Paper, Cambridge, Massachusetts2016
- The burden of skin disease in the United States.J Am Acad Dermatol. 2017; 76: 958-972 e2
- The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.J Am Acad Dermatol. 2006; 55: 490-500
- The economic burden of skin disease in the United States.J Am Acad Dermatol. 2003; 48: 592-599
- Contribution of health care factors to the burden of skin disease in the United States.J Am Acad Dermatol. 2017; 76: 1151-1160 e21
- Socioeconomic costs and health inequalities from psoriasis: a cohort study.Dermatology. 2019; 235: 372-379
- Psoriasis prevalence in adults in the United States.JAMA Dermatol. 2021; 157: 940-946
- A cross-sectional study of the distribution of psoriasis subtypes in different ethno-racial groups.Dermatol Online J. 2018; 24
- Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment.J Invest Dermatol. 2019; 139: 1672-1679 e1
- Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden.Clin Rheumatol. 2015; 34: 1753-1759
- The inpatient burden of psoriasis in the United States.J Am Acad Dermatol. 2016; 75: 33-41
- Socioeconomic disability in psoriasis.Br J Dermatol. 2009; 161: 1410-1412
- A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients.J Eur Acad Dermatol Venereol. 2015; 29: 249-254
- Ethnic and socioeconomic disparities in dermatology.J Dermatolog Treat. 2016; 27: 290-291
- Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability.J Rheumatol Suppl. 2011; 88: 55-61
- The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study.Health Qual Life Outcomes. 2018; 16: 180
- Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis.J Cutan Med Surg. 2009; 13: 192-197
- Identification, management of P, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence.J Invest Dermatol. 2013; 133: 377-385
- Health literacy: a new piece of the puzzle in psoriasis care? A cross-sectional study.Br J Dermatol. 2019; 180: 1506-1516
- Socioeconomic inequalities and severity of plaque psoriasis at a first consultation in dermatology centers.Acta Derm Venereol. 2017; 97: 632-638
- Cultural competence for the 21st century dermatologist practicing in the United States.J Am Acad Dermatol. 2017; 77: 1159-1169
- Differences in healthcare barriers based on racial and/or ethnic background for patients with psoriasis.J Dermatolog Treat. 2021; 32: 590-594
- Acne vulgaris: pathogenesis, treatment, and needs assessment.Dermatol Clin. 2012; 30 (viii-ix): 99-106
- Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women.J Eur Acad Dermatol Venereol. 2011; 25: 1054-1060
- Association of race/ethnicity and sex with differences in health care use and treatment for acne.JAMA Dermatol. 2020; 156: 312-319
- Acne disparities in Native Americans.J Am Acad Dermatol. 2021; 85: 499-501
- Readability of iPledge program patient education materials.J Am Acad Dermatol. 2018; 79: e69-e70
- Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients.J Am Acad Dermatol. 2021; 85: 1597-1599
- Relationship between sociodemographic factors and geographic distribution of pharmacies dispensing isotretinoin in Washington, DC.J Am Acad Dermatol. 2020; 83: 930-933
- Socioeconomic status influences care of patients with acne in Ontario, Canada.J Am Acad Dermatol. 2006; 54: 331-335
- Key Statistics for Melanoma Skin Cancer.Am Cancer Soc. 2022; (updated January 12, 2022. Available at:) (Accessed April 25, 2022): 5-7
- Racial disparities in melanoma survival.J Am Acad Dermatol. 2016; 75: 983-991
- Melanoma and racial health disparities in black individuals-facts, fallacies, and fixes.JAMA Dermatol. 2021; 157: 1031-1032
- Effectiveness of a knowledge-based intervention for melanoma among those with ethnic skin.J Am Acad Dermatol. 2010; 62: 777-784
- The impact of demographics, socioeconomics, and health care access on melanoma outcomes.J Am Acad Dermatol. 2021; 84: 1677-1683
- The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).J Am Acad Dermatol. 2021; 84: 1585-1593
- Factors associated with time to surgery in melanoma: an analysis of the National Cancer Database.J Am Acad Dermatol. 2019; 81: 908-916
- Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.J Am Acad Dermatol. 2018; 78: 40-46 e7
- Racial differences in time to treatment for melanoma.J Am Acad Dermatol. 2020; 83: 854-859
- Biopsy type disparities in patients with melanoma: who receives the standard of care?.Anticancer Res. 2019; 39: 6359-6363
- Un-Fair Skin: racial disparities in acral melanoma research.Nat Rev Cancer. 2022; 22: 127-128
- Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes.Cancer Control. 2014; 21: 343-349
- The expanding melanoma burden in California hispanics: Importance of socioeconomic distribution, histologic subtype, and anatomic location.Cancer. 2011; 117: 152-161
- Melanoma in Hispanic and black Americans.Cancer Control. 2008; 15: 248-253
- Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities.J Community Health. 2011; 36: 461-468
- Ethnic differences among patients with cutaneous melanoma.Arch Intern Med. 2006; 166: 1907-1914
- Melanoma in non-Caucasian populations.Surg Clin North Am. 2014; 94 (ix): 1115-1126
- Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida.Arch Dermatol. 2009; 145: 1369-1374
- The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma.Med Sci Monit. 2005; 11: RA163-RA172
- Examining the pathways linking lower socioeconomic status and advanced melanoma.Cancer. 2012; 118: 4004-4013
- Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income.J Am Acad Dermatol. 2012; 66: 771-779
- Socioeconomic determinants of melanoma-related health literacy and attitudes among college students in China: a population-based cross-sectional study.Front Public Health. 2021; 9: 743368
- Clinical practice. Hidradenitis suppurativa.N Engl J Med. 2012; 366: 158-164
- An integrated approach to unravel hidradenitis suppurativa etiopathogenesis.Front Immunol. 2019; 10: 892
- The handicap of hidradenitis suppurativa.Dermatol Clin. 2016; 34: 17-22
- Hidradenitis suppurativa burden of disease tool: pilot testing of a disease-specific quality of life questionnaire.J Am Acad Dermatol. 2018; 78: 215-217 e2
- Hidradenitis suppurativa: disease burden and etiology in skin of color.Dermatology. 2017; 233: 456-461
- Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States.JAMA Dermatol. 2017; 153: 760-764
- Clinical trials and skin of color: the example of hidradenitis suppurativa.Dermatology. 2022; 238: 180-184
- Examining the race-specific prevalence of hidradenitis suppurativa at a large academic center; results from a retrospective chart review.Dermatol Online J. 2017; 23: 1-2
- Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis.J Invest Dermatol. 2018; 138: 2152-2156
- Race-specific prevalence of hidradenitis suppurativa.J Cutan Med Surg. 2021; 25: 177-187
- Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis.Acta Derm Venereol. 2015; 95: 990-991
- Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: a retrospective analysis of 2 U.S. cohorts.JAAD Int. 2021; 3: 42-52
- Disease-specific health disparities: a targeted review focusing on race and ethnicity.Healthcare (Basel). 2022; 10
- Race and ethnicity gaps in global hidradenitis suppurativa clinical trials.Dermatology. 2021; 237: 97-102
- Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event.Br J Dermatol. 2020; 182: 1490-1492
- Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): a cross-sectional reference study.J Am Acad Dermatol. 2016; 75: 755-759 e1
- African American patients with hidradenitis suppurativa have significant health care disparities: a retrospective study.J Cutan Med Surg. 2019; 23: 334-336
- Prevalence, risk factors, and comorbidities of hidradenitis suppurativa.Dermatol Clin. 2016; 34: 7-16
- Co-morbidities in inflammatory dermatological diseases. Psoriasis, hidradenitis suppurativa, and cardiovascular risk factors.Dan Med J. 2015; 62
- Prevalence of obesity among adults, by household income and education - United States, 2011-2014.MMWR Morb Mortal Wkly Rep. 2017; 66: 1369-1373
- Prevalence of tobacco smoking and its socioeconomic determinants: tobacco smoking and its determinants.Clin Respir J. 2022; 16: 208-215
- Race and allergy: are we that different?.Ann Allergy Asthma Immunol. 2019; 122: 439-440
- Racial and ethnic differences in health care utilization for childhood eczema: an analysis of the 2001-2013 Medical Expenditure Panel Surveys.J Am Acad Dermatol. 2017; 77: 1060-1067
- Association of stress with symptoms of atopic dermatitis.Acta Derm Venereol. 2010; 90: 582-588
- Psychological stress and atopic dermatitis severity following the COVID-19 pandemic and an earthquake.Psychiatr Danub. 2021; 33: 393-401
- Impact of social determinants on the burden of asthma and eczema: results from a US patient survey.Adv Ther. 2022; 39: 1341-1358
- Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health.J Invest Dermatol. 2011; 131: 67-73
- The socioeconomics of atopic dermatitis.Ann Allergy Asthma Immunol. 2019; 122: 360-366
- Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations.J Allergy Clin Immunol. 2021; 148: 1104-1111
- Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population.J Invest Dermatol. 2019; 139: 583-590
- Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study.J Allergy Clin Immunol. 2013; 132: 1132-1138
- Impact of socioeconomic and environmental factors on atopic eczema and allergic rhinitis: a cross sectional study.EXCLI J. 2015; 14: 1040-1048
- The prevalence and persistence of atopic dermatitis in urban United States children.Ann Allergy Asthma Immunol. 2019; 123: 173-178 e1
- Structural racism and its pathways to asthma and atopic dermatitis.J Allergy Clin Immunol. 2021; 148: 1112-1120
- Socioeconomic disparities in health: pathways and policies.Health Aff (Millwood). 2002; 21: 60-76
- Associations of childhood eczema severity: a US population-based study.Dermatitis. 2014; 25: 107-114
- Structural racism and its influence on the severity of atopic dermatitis in African American children.Pediatr Dermatol. 2020; 37: 142-146
Article info
Footnotes
Dr V. Harvey is director and researcher of the Hampton University Skin of Color Research Institute, Hampton, VA, USA and a dermatologist at the Hampton Roads Center for Dermatology, Newport News, VA, USA and Virginia Beach, VA, USA.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
